Penelope Brock


Penelope Brock (known as Peppy) gained her medical degree in 1981 and Specialisation in Paediatrics in 1986 from Louvain University in Belgium. She moved to Leuven University in 1988, after two years as Leukaemia Research Fellow at Great Ormond Street Hospital, and became Associate Professor of Paediatrics heading up the children’s haematology and oncology department. She returned to London in 1999 as Consultant Paediatric Oncologist and Honorary Senior Lecturer at Great Ormond Street and University College London Hospital where she currently works fulltime for the NHS. Her doctoral degree was on cisplatin toxicity in infants and children. She developed the Brock grading system for cisplatin ototoxicity. She is UK Chief Investigator for a number of international clinical trials, including the European High-Risk Neuroblastoma Trial run by SIOPEN and International Chairman of the 6th International Paediatric Liver Tumour Trial run by SIOPEL. This is a prospective randomised study of the chemoprotectant, sodium thiosulphate, and its prevention of cisplatin ototoxicity. She is a member of the International Society of Paediatric Oncology SIOP and on different European tumour working groups. She is currently President of the European neuroblastoma group SIOPEN.  She is medical trustee for a number of charities and on the editorial board of Coping with Cancer in the 21st Century. She is married to Paul, lives in Kent and has 4 children and 4 step children.